Stage IVC Lip and Oral Cavity Cancer AJCC v8 Clinical Trials in Rochester, Minnesota

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population